4 October 2016 | Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study | Walter, FM; Mills, K; Mendonça, SC; et al. |
27 August 2020 | Effect of pre-existing conditions on bladder cancer stage at diagnosis: a cohort study using electronic primary care records in the UK | Carney, M; Quiroga, M; Mounce, L; et al. |
2 August 2021 | Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study | Herbert, A; Rafiq, M; Pham, TM; et al. |
27 May 2021 | CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | Funston, G; Mounce, LT; Price, S; et al. |
20 April 2022 | Diagnoses after newly-recorded abdominal pain in primary care: observational cohort study | Price, S; Gibson, N; Hamilton, W; et al. |
19 June 2021 | Guideline interval: A new time interval in the diagnostic pathway for symptomatic cancer | Price, S; Abel, GA; Hamilton, W |
28 October 2020 | The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study | Funston, G; Hamilton, W; Abel, G; et al. |
15 May 2022 | A prospective evaluation of the fourth Be Clear on Cancer ‘Blood in Pee’ campaign in England | Merriel, SWD; Ball, S; Bright, CJ; et al. |
8 August 2022 | Revising the suspected-cancer guidelines: Impacts on patients’ primary care contacts and costs | Price, S; Landa, P; Mujica-Mota, R; et al. |
19 January 2021 | Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England. | Bailey, SER; Abel, GA; Atkins, A; et al. |